MMP-12 inhibitors (CEA)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameMMP-12 inhibitors (CEA)
Drug Alias NameRXP-470 derivatives (CEA)RXP-470
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 12 inhibitors
TargetsMatrix metalloproteinase 12
Therapy Area/IndicationsAtherosclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A
Related LinksN/A